Literature DB >> 7369870

Fatal sotalol poisoning.

M Montagna, A Groppi.   

Abstract

Sotalol [4-(2-isopropylamino-1-hydroxyethyl)-methane-sulfonanilide hydrochloride] is a beta-adrenergic blocking agent. Despite the widespread use of these drugs, poisonings are not frequent. In this report the authors describe the first recorded case of fatal sotalol overdosage to their knowledge. The results of toxicological analysis, performed by a specially developed method, are presented, and compared with findings in fatal intoxications with other beta-adrenergic blocking agents.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7369870     DOI: 10.1007/bf00297587

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  9 in total

1.  Letter: Massive intoxication with metoprolol.

Authors:  B H Moller
Journal:  Br Med J       Date:  1976-01-24

2.  Human pharmacokinetics of sotalol.

Authors:  M Anttila; M Arstila; M Pfeffer; R Tikkanen; V Vallinkoski; H Sundquist
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1976-07

3.  Attempted suicide with 5.1 g of propranolol. A case report.

Authors:  J Lagerfelt; G Matell
Journal:  Acta Med Scand       Date:  1976

4.  Antihypertensive effects of practolol and sotalol.

Authors:  H Sundquist; M Anttila; M Arstila
Journal:  Clin Pharmacol Ther       Date:  1974-09       Impact factor: 6.875

5.  Separation and spectrofluorometric assay of the -adrenergic blocker sotalol from blood and urine.

Authors:  E R Garrett; K Schnelle
Journal:  J Pharm Sci       Date:  1971-06       Impact factor: 3.534

6.  Suicide attempt with practolol.

Authors:  P Karhunen; G Härtel
Journal:  Br Med J       Date:  1973-04-21

7.  GLC determination of propranolol, other beta-blocking drugs, and metabolites in biological fluids and tissues.

Authors:  T Walle
Journal:  J Pharm Sci       Date:  1974-12       Impact factor: 3.534

8.  A death involving propranolol (Inderal).

Authors:  R Gault; J R Monforte; S Khasnabis
Journal:  Clin Toxicol       Date:  1977       Impact factor: 4.467

9.  The effect of end-stage renal failure and haemodialysis on the elimination kinetics of sotalol.

Authors:  T B Tjandramaga; R Verbeeck; J Thomas; R Verbesselt; R Verberckmoes; P J Schepper
Journal:  Br J Clin Pharmacol       Date:  1976-04       Impact factor: 4.335

  9 in total
  8 in total

1.  [Torsade de pointes tachycardia during administration of quinidine and verapamil in atrial fibrillation].

Authors:  M Karch; C Schmitt; A Plewan; G Schmidt; A Schömig
Journal:  Herz       Date:  1997-02       Impact factor: 1.443

2.  Prolonged Q-T interval and severe tachyarrhythmias, common features of sotalol intoxication.

Authors:  P J Neuvonen; E Elonen; T Vuorenmaa; M Laakso
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

Review 3.  Sotalol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.

Authors:  B N Singh; P Deedwania; K Nademanee; A Ward; E M Sorkin
Journal:  Drugs       Date:  1987-09       Impact factor: 9.546

Review 4.  Sotalol. An updated review of its pharmacological properties and therapeutic use in cardiac arrhythmias.

Authors:  A Fitton; E M Sorkin
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

Review 5.  Class III antiarrhythmics in overdose. Presenting features and management principles.

Authors:  E W Leatham; D W Holt; W J McKenna
Journal:  Drug Saf       Date:  1993-12       Impact factor: 5.606

Review 6.  QT-interval prolonging drugs: mechanisms and clinical relevance of their arrhythmogenic hazards.

Authors:  M Zehender; S Hohnloser; H Just
Journal:  Cardiovasc Drugs Ther       Date:  1991-04       Impact factor: 3.727

Review 7.  Drug-induced torsade de pointes. Incidence, management and prevention.

Authors:  T S Faber; M Zehender; H Just
Journal:  Drug Saf       Date:  1994-12       Impact factor: 5.606

8.  Sotalol poisoning associated with asystole.

Authors:  F Alderfliegel; M Leeman; P Demaeyer; R J Kahn
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.